N
SRRA

Nuveen’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Nuveen’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-54,078
Closed -$2.97M – 3319
2022
Q2 		$2.97M Buy
+54,078
New +$2.84M ﹤0.01% 2230

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Nuveen's SRRA Position: Q3 2022 in Review

Nuveen sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 54,078 shares — an estimated $2.97M sold.

Nuveen first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $2.97M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Nuveen reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Nuveen sold 54,078 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $2.97M.
  • Nuveen first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Nuveen's Sierra Oncology, Inc. Common Stock position peaked at $2.97M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.